ID   OCGH_ATRT
AC   CVCL_A1GR
SY   AT/RT
DR   cancercelllines; CVCL_A1GR
DR   JCRB; JCRB1868
DR   Wikidata; Q102114678
RX   PubMed=32997328;
CC   Population: Japanese.
CC   Doubling time: 19.3 hours (PubMed=32997328).
CC   Sequence variation: Mutation; HGNC; 11103; SMARCB1; Simple; p.Arg53Ter (c.157C>T); ClinVar=VCV000944246; Zygosity=Unspecified (PubMed=32997328).
CC   Misspelling: ATRT_OCGH; PubMed=32997328; Note=In abstract.
CC   Derived from site: In situ; Brain, pineal gland; UBERON=UBERON_0001905.
ST   Source(s): JCRB=JCRB1868; PubMed=32997328
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 10,11
ST   D16S539: 9,11
ST   D21S11: 30,31.2
ST   D5S818: 10,11
ST   D7S820: 12
ST   TH01: 6,9
ST   TPOX: 8
ST   vWA: 14,17
DI   NCIt; C6906; Atypical teratoid/rhabdoid tumor
DI   ORDO; Orphanet_99966; Atypical teratoid rhabdoid tumor
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   10M
CA   Cancer cell line
DT   Created: 29-10-20; Last updated: 02-05-24; Version: 9
//
RX   PubMed=32997328; DOI=10.1007/s13577-020-00438-3;
RA   Nakano Y., Takadera M., Miyazaki M., Qiao Z.-W., Nakajima K., Noguchi R.,
RA   Oyama R., Kimura Y., Okuhiro Y., Yamasaki K., Kunihiro N.,
RA   Fukushima H., Inoue T., Hara J., Ozawa T., Kondo T., Ichimura K.;
RT   "Drug screening with a novel tumor-derived cell line identified
RT   alternative therapeutic options for patients with atypical
RT   teratoid/rhabdoid tumor.";
RL   Hum. Cell 34:271-278(2021).
//